111, Inc. (YI)

USD 8.4

(1.82%)

Operating Expenses Summary of 111, Inc.

111, Inc.'s latest annual operating expenses in 2023 was 798.53 Million CNY , down -0.98% from previous year.
111, Inc.'s latest quarterly operating expenses in 2024 Q2 was 204.26 Million CNY , down -43.26% from previous quarter.
111, Inc. reported a annual operating expenses of 1.21 Billion CNY in annual operating expenses 2022, down -4.14% from previous year.
111, Inc. reported a annual operating expenses of 1.26 Billion CNY in annual operating expenses 2021, up 50.54% from previous year.
111, Inc. reported a quarterly operating expenses of 204.8 Million CNY for 2024 Q1, down -34.92% from previous quarter.
111, Inc. reported a quarterly operating expenses of 1.19 Billion CNY for 2023 FY, down -0.98% from previous quarter.

Annual Operating Expenses Chart of 111, Inc. (2023 - 2016)

Historical Annual Operating Expenses of 111, Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	798.53 Million CNY	-0.98%
2022	1.21 Billion CNY	-4.14%
2021	1.26 Billion CNY	50.54%
2020	839.14 Million CNY	27.39%
2019	658.69 Million CNY	30.53%
2018	504.64 Million CNY	46.36%
2017	344.78 Million CNY	-21.97%
2016	441.88 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	204.26 Million CNY	-43.26%
2024 Q1	204.8 Million CNY	-34.92%
2023 FY	1.19 Billion CNY	-0.98%
2023 Q1	257.94 Million CNY	-28.73%
2023 Q2	249.29 Million CNY	-3.35%
2023 Q3	271.04 Million CNY	8.73%
2023 Q4	314.69 Million CNY	16.1%
2022 FY	1.21 Billion CNY	-4.14%
2022 Q2	271.72 Million CNY	-7.79%
2022 Q4	361.91 Million CNY	28.04%
2022 Q3	282.65 Million CNY	4.02%
2022 Q1	294.68 Million CNY	-4.75%
2021 Q1	289.03 Million CNY	16.42%
2021 FY	1.26 Billion CNY	50.54%
2021 Q3	341.42 Million CNY	5.57%
2021 Q4	309.37 Million CNY	-9.38%
2021 Q2	323.4 Million CNY	11.89%
2020 Q1	201.29 Million CNY	-4.4%
2020 Q3	212.11 Million CNY	19.53%
2020 Q4	248.27 Million CNY	17.05%
2020 FY	839.14 Million CNY	27.39%
2020 Q2	177.45 Million CNY	-11.84%
2019 Q2	142.93 Million CNY	2.26%
2019 FY	658.69 Million CNY	30.53%
2019 Q1	139.77 Million CNY	-10.02%
2019 Q4	210.56 Million CNY	27.29%
2019 Q3	165.42 Million CNY	15.73%
2018 Q2	120.55 Million CNY	44.73%
2018 Q4	155.33 Million CNY	6.79%
2018 Q1	83.3 Million CNY	-5.72%
2018 Q3	145.45 Million CNY	20.65%
2018 FY	504.64 Million CNY	46.36%
2017 Q2	71.3 Million CNY	2.38%
2017 FY	344.78 Million CNY	-21.97%
2017 Q4	88.35 Million CNY	-2.05%
2017 Q1	69.64 Million CNY	0.0%
2017 Q3	90.2 Million CNY	26.5%
2016 FY	441.88 Million CNY	0.0%

Peer Operating Expenses Comparison of 111, Inc.

Name	Operating Expenses	Operating Expenses Difference
CannBioRx Life Sciences Corp.	13.47 Million USD	-5824.964%
China Jo-Jo Drugstores, Inc.	34.64 Million USD	-2205.038%
Harrow Health, Inc. 8.625% Senior Notes due 2026	89.97 Million USD	-787.53%
Harrow Health, Inc. 11.875% Senior Notes due 2027	90.12 Million USD	-786.062%
Leafly Holdings, Inc.	44.5 Million USD	-1694.385%
LifeMD, Inc.	148.13 Million USD	-439.057%
LifeMD, Inc.	148.13 Million USD	-439.057%
TRxADE HEALTH, Inc.	9.86 Million USD	-7997.387%
PetMed Express, Inc.	86.81 Million USD	-819.868%
Walgreens Boots Alliance, Inc.	40.6 Billion USD	98.033%